SCHEMBL30337805

SCHEMBL30337805

Fc1ccc(-n2c(C3CCOCC3)c(OCc3ccccc3)c3ccccc32)cc1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 1/20 0.45
RORC P51449 2/20 0.39
HTR1A P08908 2/20 0.36
SLC6A2 P23975 2/20 0.36
SLC6A4 P31645 2/20 0.36
SLC6A3 Q01959 2/20 0.36
PDE9A O76083 1/20 0.35
GRM5 P41594 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
ALDH1A1 P00352 2/20 0.35
USP14 P54578 1/20 0.35
CNR2 P34972 2/20 0.35
CNR1 P21554 1/20 0.35
AOC3 Q16853 1/20 0.34
MEN1 O00255 1/20 0.34
POLB P06746 1/20 0.34
KMT2A Q03164 1/20 0.34
MCHR1 Q99705 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30234490 0.83 SCN9A (0.35) SCN9AHTR1ASLC6A2SLC6A4SLC6A3
SCHEMBL23883828 0.82 SCN9A (0.39) SCN9ARORCHTR1ASLC6A2SLC6A4
SCHEMBL23883735 0.81 SCN9A (0.42) SCN9ARORCHTR1ASLC6A2SLC6A4
SCHEMBL23883696 0.81 SCN9A (0.40) SCN9ARORCHTR1ASLC6A2SLC6A4
SCHEMBL23883622 0.80 SCN9A (0.43) SCN9ARORCHTR1ASLC6A2SLC6A4
SCHEMBL30176308 0.79 AS3MT (0.47) SCN9ARORCALDH1A1CNR2CNR1
SCHEMBL23886826 0.79 AS3MT (0.47) SCN9ARORCALDH1A1CNR2CNR1
SCHEMBL28995442 0.78 SCN9A (0.40) SCN9ARORCHTR1ASLC6A2SLC6A4
SCHEMBL23884077 0.77 SCN9A (0.39) SCN9ARORCHTR1ASLC6A2SLC6A4
SCHEMBL23883771 0.77 SCN9A (0.37) SCN9ARORCHTR1ASLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115916749-A Substituted 5-hydroxyindole compounds as alpha-1 antitrypsin modulators 弗特克斯药品有限公司 2023-04-04 CN disclosed